Wednesday, November 05, 2025 12:43:46 PM
GGB, how about some reality on the NICE timeline issue.
NICE is in the processing of changing this as we speak. So let us talk old and new,
In the old process the company can submit the NICE application (the scientific evidence) prior to the MHRA approval. Nice will evaluate it and form a draft opinion. But that remains unpublished until the MHRA approval. It is the process of evaluating in advance that allows NICE to sometimes issue the opinion within days of the MHRA approval. But there still is a mandatory period for public review before being final.
In the new process, they are allowing the process to goi public with the review even prior to MHRA approval. The means the final opinion can be prior to MHRA approval but is conditional on approval. Thus allowing the full same day decision.
Either way the evaluation can happen prior to MHRA decision. But either way it starts with the company submission to NICE, which has not happened for NWBO.
Until recently I thought it might well happen. Not that expensive and give NWBO a talking point. Alas with the process now going public I doubt LP will submit it. For some reason LP has an issue with the peasants knowing what she is up to.
NICE is in the processing of changing this as we speak. So let us talk old and new,
In the old process the company can submit the NICE application (the scientific evidence) prior to the MHRA approval. Nice will evaluate it and form a draft opinion. But that remains unpublished until the MHRA approval. It is the process of evaluating in advance that allows NICE to sometimes issue the opinion within days of the MHRA approval. But there still is a mandatory period for public review before being final.
In the new process, they are allowing the process to goi public with the review even prior to MHRA approval. The means the final opinion can be prior to MHRA approval but is conditional on approval. Thus allowing the full same day decision.
Either way the evaluation can happen prior to MHRA decision. But either way it starts with the company submission to NICE, which has not happened for NWBO.
Until recently I thought it might well happen. Not that expensive and give NWBO a talking point. Alas with the process now going public I doubt LP will submit it. For some reason LP has an issue with the peasants knowing what she is up to.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
